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underlying principles have been revised.
Liou et al. reported improved survival for only 5 out of 514
patients (1%) in the pediatric CF population listed for lung
transplantation in the USA [1]. They reached the conclusion that
prolongation of life by means of lung transplantation should not
be expected in children with cystic fibrosis.
The informative 1% figure addresses the crucial issue of
innovative practices and their predictability. The practice of
medicine is viewed as a fundamental and social science
embracing statistical and human parameters that cannot be
reduced to probability measurements. Such measurements play
a highlighting and clarifying role but cannot suffice to transcribe
the actual data of post-transplant survival. Thus, the quantified
criteria of the patient's quality of life should be questioned:
which aspects should be included or deleted? At this stage, two
approaches should be delineated: either to make a rash decision
and mark a temporary pause in this current practice or to
provide enlightening criticism so as to understand the reasons
behind such poor results. At first sight, this retrospective study
has two evidently biased approaches resting on the two-group
population studied and the lung allocation score (LAS) used.
The former lay on an irrelevant comparison between the listed
and the not-listed groups. The latter focused on the formerly1569-1993/$ - see front matter © 2008 European Cystic Fibrosis Society. Publishe
doi:10.1016/j.jcf.2008.03.010used LAS based on the patients' waiting time on list and not
their clinical status. The former LAS was upgraded in 2005 and
now focuses on the patient's specific clinical status and disease.
A prospective, randomized trial using the new LAS in the
USA [2] and additional studies in other countries should be
carried out that might highlight acceptable results in CF
pediatric lung transplantation.
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